相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection
Caroline Sheitoyan-Pesant et al.
CLINICAL INFECTIOUS DISEASES (2016)
Role of binary toxin in the outcome of Clostridium difficile infection in a non-027 ribotype setting
E. Reigadas et al.
EPIDEMIOLOGY AND INFECTION (2016)
The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations
S. D. Goldenberg et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Factors predictive of severe Clostridium difficile infection depend on the definition used
Nagham Khanafer et al.
ANAEROBE (2016)
Binary toxin and its clinical importance in Clostridium difficile infection, Belgium
T. Pilate et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
Maureen Watt et al.
INFECTION (2016)
Evaluation of a bedside scoring system for predicting clinical cure and recurrence of Clostridium difficile infections
Shauna M. Jacobson et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2015)
Current status of the treatment of fulminant colitis
Manuel Ferrer Marquez et al.
CIRUGIA ESPANOLA (2015)
Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain
C. Rubio-Terres et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
Abhishek Deshpande et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era
Christopher R. Polage et al.
JAMA INTERNAL MEDICINE (2015)
Fidaxomicin Therapy in Critically Ill Patients with Clostridium difficile Infection
Samuel Penziner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Risk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors
Ralph B. D'Agostino et al.
CLINICAL INFECTIOUS DISEASES (2014)
Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection
Dilip Nathwani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach
E. van Kleef et al.
JOURNAL OF HOSPITAL INFECTION (2014)
Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID)
Kerrie A. Davies et al.
LANCET INFECTIOUS DISEASES (2014)
Multistate Point- Prevalence Survey of Health Care- Associated Infections
Shelley S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review
Claire Nour Abou Chakra et al.
PLOS ONE (2014)
An Antimicrobial Stewardship Program's Real-World Experience with Fidaxomicin for Treatment of Clostridium difficile Infection: A Case Series
Craig A. Vargo et al.
PHARMACOTHERAPY (2014)
The Use of Fidaxomicin for Treatment of Relapsed Clostridium difficile Infections in Patients with Cancer
Amin Esmaily-Fard et al.
PHARMACOTHERAPY (2014)
Fidaxomicin Chaser Regimen Following Vancomycin for Patients With Multiple Clostridium difficile Recurrences
Stuart Johnson et al.
CLINICAL INFECTIOUS DISEASES (2013)
Predicting Recurrence of C-difficile Colitis Using Bacterial Virulence Factors: Binary Toxin Is the Key
David B. Stewart et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Clostridium difficile infections in South East Scotland: mortality and recurrence in a region without PCR ribotype 027
Surabhi K. Taori et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection
Timothy D. Planche et al.
LANCET INFECTIOUS DISEASES (2013)
Fidaxomicin Failures in Recurrent Clostridium difficile Infection: A Problem of Timing
Robert Orenstein
CLINICAL INFECTIOUS DISEASES (2012)
Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
Thomas J. Louie et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fidaxomicin Inhibits Spore Production in Clostridium difficile
Farah Babakhani et al.
CLINICAL INFECTIOUS DISEASES (2012)
Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection
P. N. Wiegand et al.
JOURNAL OF HOSPITAL INFECTION (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
Presumptive Identification of Clostridium difficile Strain 027/NAP1/BI on Cepheid Xpert: Interpret with Caution
Jen Kok et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile
Simon D. Goldenberg et al.
JOURNAL OF INFECTION (2011)
Killing kinetics of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile
Farah Babakhani et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection
Mary Y. Hu et al.
GASTROENTEROLOGY (2009)
Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients
Erik R. Dubberke et al.
EMERGING INFECTIOUS DISEASES (2008)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
J Pépin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
分享论文
